mRNA Webinar Series:
mRNA technology offers many opportunities but the development and manufacturing of mRNA-based vaccines and therapeutics present a number of challenges. Learn more about the opportunities of the mRNA technology and how to overcome drug development and manufacturing challenges to bring your mRNA-based therapies to market in this first webinar.
In this webinar, you will learn:
- Which key parameters impact mRNA manufacturing speed, capacities as well as quality
- Understand the benefits of our flexible GMP mRNA manufacturing platform for clinical and commercial mRNA demands
- How our innovative PCR-based process can accelerate your mRNA development and manufacturing program
- mRNA CDMO Services as part of our highly connected network to ensure speed, scalability, quality and flexibility for mRNA, lipid, LNP formulation and Fill & Finish
Detailed description:
To unlock the potential of your mRNA therapies and accelerate your mRNA development and manufacturing program, discover the benefits of our novel PCR-based mRNA drug substance manufacturing process. With this innovative and flexible process, we can provide mRNA at all scales and qualities for all stages of a mRNA program life cycle, from pre-clinical to commercial.
Learn about our truly integrated mRNA-LNP CDMO offering, and how we can support you as the single-source partner along all critical steps from mRNA drug substance manufacturing, through lipids and lipid nanoparticle (LNPs) to fill & finish of the final drug product.
To view this webinar, click here.
